Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)
CNY 18.41
(-1.13%)
CNY 18.41
(-1.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 519.62 Million | 531.29 Million | 632.95 Million | 622.76 Million | 641.8 Million | 577.65 Million |
| Cost of Revenue | 257.76 Million | 220.09 Million | 204.37 Million | 171.41 Million | 167.76 Million | 142.29 Million |
| Gross Profit | 261.85 Million | 311.19 Million | 428.57 Million | 451.34 Million | 474.03 Million | 435.35 Million |
| Operating Expenses | 262.87 Million | 250.36 Million | 324.3 Million | 289.5 Million | 323.5 Million | 326.63 Million |
| Selling, General and Administrative Expenses | 216.4 Million | 198.57 Million | 276.46 Million | 279.97 Million | 283.89 Million | 281.18 Million |
| Research and Development Expenses | 42.79 Million | 39.32 Million | 37.01 Million | 20.4 Million | 21.16 Million | 16.39 Million |
| Other Expenses | 1.44 Million | -1.7 Million | 886.02 Thousand | -5.64 Million | 481.65 Thousand | 6.75 Million |
| Cost and Expenses | 520.63 Million | 470.46 Million | 528.67 Million | 460.92 Million | 491.27 Million | 468.93 Million |
| Operating Income | -1.01 Million | 59.45 Million | 99.14 Million | 159.03 Million | 147.1 Million | 103.39 Million |
| Interest Expense | 9.44 Million | 5.4 Million | 2.15 Million | 253.35 Thousand | 2.03 Million | 4.06 Million |
| Income Tax Expense | 398.59 Thousand | 12.63 Million | 3.48 Million | 22.99 Million | 21.62 Million | 15.62 Million |
| Earnings before Tax | -5.78 Million | 57.75 Million | 100.02 Million | 158.7 Million | 147.63 Million | 103.39 Million |
| Net Income | -8.03 Million | 48.81 Million | 96.49 Million | 135.81 Million | 126.01 Million | 87.77 Million |
| Earnings Per Share Basic | -0.06 | 0.31 | 0.67 | 0.94 | 0.87 | 0.81 |
| Earnings Per Share Diluted | -0.06 | 0.31 | 0.67 | 0.94 | 0.87 | 0.81 |
| Weighted Average Shares Outstanding | 133.97 Million | 144.79 Million | 144.79 Million | 144.79 Million | 144.79 Million | 108.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 133.97 Million | 144.79 Million | 144.79 Million | 144.79 Million | 144.79 Million | 108.96 Million |
| Gross Margin | 0.50 | 0.59 | 0.68 | 0.72 | 0.74 | 0.75 |
| EBIT Margin | 0.10 | 0.22 | 0.22 | 0.29 | 0.26 | 0.21 |
| Profit Margin | -0.02 | 0.09 | 0.15 | 0.22 | 0.20 | 0.15 |
| EBITDA | 53.23 Million | 113.72 Million | 132.18 Million | 174.92 Million | 165.81 Million | 111.89 Million |
| Earnings Before Tax Margin | -0.00 | 0.11 | 0.16 | 0.26 | 0.23 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 73.86 Million | 96.17 Million | 199.95 Million | 87.61 Million | 519.62 Million | 115.56 Million |
| Cost of Revenue | 51.21 Million | 47.08 Million | 102.12 Million | 76.94 Million | 257.76 Million | 40.14 Million |
| Gross Profit | 22.64 Million | 49.08 Million | 97.82 Million | 10.67 Million | 261.85 Million | 75.41 Million |
| Operating Expenses | 75.14 Million | 61.62 Million | 68.62 Million | 116.33 Million | 284.45 Million | 51.52 Million |
| Selling, General and Administrative Expenses | 131.76 Million | 58.32 Million | 63.11 Million | 64.17 Million | - | 64.65 Million |
| Research and Development Expenses | 5.6 Million | 3.24 Million | 2.97 Million | 22.93 Million | - | 3.38 Million |
| Other Expenses | -62.22 Million | -57.58 Thousand | -282.95 Thousand | 335.62 Thousand | -4.77 Million | -4.57 Million |
| Cost and Expenses | 126.36 Million | 108.71 Million | 170.75 Million | 193.28 Million | 542.22 Million | 91.67 Million |
| Operating Income | 34.49 Million | -12.54 Million | 26.63 Million | -95.2 Million | -1.01 Million | 20.3 Million |
| Interest Expense | 1.02 Million | 1.93 Million | 1.24 Million | 3.33 Million | 9.44 Million | 2.59 Million |
| Income Tax Expense | -2.49 Million | -1.84 Million | 1.96 Million | -17.81 Million | 398.59 Thousand | 10.37 Million |
| Earnings before Tax | 27.73 Million | -10.25 Million | 26.35 Million | -94.87 Million | -5.78 Million | 15.72 Million |
| Net Income | 29.9 Million | -10.14 Million | 24.33 Million | -77.38 Million | -8.03 Million | 4.72 Million |
| Earnings Per Share Basic | 0.21 | -0.07 | 0.17 | -0.63 | - | 0.03 |
| Earnings Per Share Diluted | 0.21 | -0.07 | 0.17 | -0.63 | - | 0.03 |
| Weighted Average Shares Outstanding | 142.05 Million | 142.05 Million | 143.14 Million | 123.16 Million | 133.97 Million | 144.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 142.05 Million | 142.05 Million | 143.14 Million | 123.16 Million | 133.97 Million | 144.79 Million |
| Gross Margin | 0.31 | 0.51 | 0.49 | 0.12 | 0.50 | 0.65 |
| EBIT Margin | 0.39 | 0.02 | 0.15 | -1.11 | - | 0.18 |
| Profit Margin | 0.40 | -0.11 | 0.12 | -0.88 | -0.02 | 0.04 |
| EBITDA | 28.75 Million | 2.22 Million | 30.44 Million | -97.66 Million | - | 20.25 Million |
| Earnings Before Tax Margin | 0.47 | -0.13 | 0.13 | -1.09 | -0.00 | 0.18 |
QRIL
300596
MANGIND
KSCL
002197
2901